Year: 2018

Announcing a new drug can have a significant impact on the share price for a biotech firm. That is particularly true if the drug can revolutionize treatment. Likewise, repeated trading at higher prices shortly before the close of the market …

BioTech CEO Charged with Securities Fraud, Manipulation Read More »

Tagged with: , ,

Fresh from his remarks about not “piling on,” Deputy Attorney General Rod Rosenstein turned to the question of compliance and its impact. Threaded through the discussion were remarks about the fiduciary duties of lawyers advising firms. Remarks, Compliance Week’s 2018 …

Deputy AG On Compliance And Lawyer’s Fiduciary Duties Read More »

Tagged with: , ,